Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror
dc.contributor.author | Waning, David L. | |
dc.contributor.author | Mohammad, Khalid S. | |
dc.contributor.author | Guise, Theresa A. | |
dc.contributor.department | Department of Medicine, School of Medicine | en_US |
dc.date.accessioned | 2015-09-02T21:09:18Z | |
dc.date.available | 2015-09-02T21:09:18Z | |
dc.date.issued | 2013-10-14 | |
dc.description.abstract | Tumor-bone cell interactions are critical for the development of metastasis-related osteolytic bone destruction. In this issue of Cancer Cell, Ell and colleagues show how a discrete miRNA network regulates osteoclastogenesis during breast cancer bone metastasis. A signature of upregulated miRNAs may have diagnostic and therapeutic implications for bone metastases. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Waning, D. L., Mohammad, K. S., & Guise, T. A. (2013). Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror. Cancer Cell, 24(4), 407–409. http://doi.org/10.1016/j.ccr.2013.10.001 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/6712 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.ccr.2013.10.001 | en_US |
dc.relation.journal | Cancer Cell | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Animals | en_US |
dc.subject | Bone Neoplasms/pathology | en_US |
dc.subject | Humans | en_US |
dc.subject | MicroRNAs/metabolism | en_US |
dc.subject | Osteoclasts/cytology | en_US |
dc.subject | Tumor Markers, Biological/metabolism | en_US |
dc.title | Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror | en_US |
dc.type | Article | en_US |